• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院患者接受治疗性血浆置换的出血结局:国家住院患者样本的倾向评分匹配分析。

Bleeding outcomes of inpatients receiving therapeutic plasma exchange: A propensity-matched analysis of the National Inpatient Sample.

机构信息

Department of Medicine, Faculdade de Medicina de São José do Rio Preto, São Paulo, Brazil.

Duke University School of Medicine, Durham, North Carolina, USA.

出版信息

Transfusion. 2022 Feb;62(2):386-395. doi: 10.1111/trf.16769. Epub 2021 Dec 18.

DOI:10.1111/trf.16769
PMID:34907537
Abstract

BACKGROUND

Although therapeutic plasma exchange (TPE) is associated with hemostatic abnormalities, its impact on bleeding outcomes is unknown. Therefore, the main study objective was to determine bleeding outcomes of inpatients treated with TPE.

STUDY DESIGN AND METHODS

In a cross-sectional analysis of the National Inpatient Sample (NIS), discharges were identified with 10 common TPE-treated conditions. A 1:3 propensity-matched analysis of TPE- to non-TPE-treated discharges was performed. The primary outcome was major bleeding and secondary outcomes were packed red blood cell (PRBC) transfusion, mortality, disposition, hospital length of stay (LOS), and charges. Multivariable regression analyses were used to examine the association between TPE and study outcomes.

RESULTS

The study population was 15,964 discharges, of which 3991 were TPE- treated. The prevalence of major bleeding was low (5.4%). When compared to non-TPE discharges, TPE had a significant and positive association with major bleeding (OR = 1.37, 95% CI: 1.16-1.63, p = .0003). TPE was also associated with PRBC transfusion (OR = 1.66, 95% CI: 1.42-1.94, p < .0001), in-hospital mortality (OR = 1.45, 95% CI: 1.10-1.90, p = .0008), hospital length of stay (12.45 [95% CI: 11.95-12.97] vs. 7.38 [95% CI: 7.12-7.65] days, p < .0001) and total charges, ($125,123 [95% CI: $119,220-$131,317] vs. $61,953 [95% CI: $59,391-$64,625], p < .0001), and disposition to non-self-care (OR = 1.29, 95% CI: 1.19-1.39, p < .0001).

DISCUSSION

The use of TPE in the inpatient setting is positively associated with bleeding; however, with low prevalence. Future studies should address risk factors that predispose patients to TPE-associated bleeding.

摘要

背景

尽管治疗性血浆置换(TPE)与止血异常有关,但它对出血结局的影响尚不清楚。因此,主要研究目的是确定接受 TPE 治疗的住院患者的出血结局。

研究设计和方法

在国家住院患者样本(NIS)的横断面分析中,确定了 10 种常见 TPE 治疗情况的出院患者。对 TPE 治疗和非 TPE 治疗出院患者进行了 1:3 倾向匹配分析。主要结局是大出血,次要结局是输红细胞悬液(PRBC)、死亡率、处置、住院时间(LOS)和费用。多变量回归分析用于检查 TPE 与研究结局之间的关联。

结果

研究人群为 15964 例出院患者,其中 3991 例接受 TPE 治疗。大出血的发生率较低(5.4%)。与非 TPE 出院患者相比,TPE 与大出血有显著正相关(OR=1.37,95%CI:1.16-1.63,p=0.0003)。TPE 还与 PRBC 输血(OR=1.66,95%CI:1.42-1.94,p<0.0001)、住院内死亡率(OR=1.45,95%CI:1.10-1.90,p=0.0008)、住院时间(12.45[95%CI:11.95-12.97]vs.7.38[95%CI:7.12-7.65]天,p<0.0001)和总费用($125123[95%CI:$119220-$131317]vs.$61953[95%CI:$59391-$64625],p<0.0001)以及非自我护理处置(OR=1.29,95%CI:1.19-1.39,p<0.0001)有关。

讨论

TPE 在住院环境中的使用与出血呈正相关,但出血发生率较低。未来的研究应解决使患者易发生 TPE 相关出血的风险因素。

相似文献

1
Bleeding outcomes of inpatients receiving therapeutic plasma exchange: A propensity-matched analysis of the National Inpatient Sample.住院患者接受治疗性血浆置换的出血结局:国家住院患者样本的倾向评分匹配分析。
Transfusion. 2022 Feb;62(2):386-395. doi: 10.1111/trf.16769. Epub 2021 Dec 18.
2
Central venous catheters are associated with thrombosis among adult inpatients undergoing therapeutic plasma exchange.中心静脉导管与接受治疗性血浆置换的成年住院患者的血栓形成有关。
J Clin Apher. 2022 Aug;37(4):340-347. doi: 10.1002/jca.21975. Epub 2022 Feb 22.
3
Use of therapeutic plasma exchange in heparin-induced thrombocytopenia: A population-based study.在肝素诱导的血小板减少症中使用治疗性血浆置换:一项基于人群的研究。
J Clin Apher. 2021 Jun;36(3):398-407. doi: 10.1002/jca.21876. Epub 2021 Jan 16.
4
In hospitalized patients undergoing therapeutic plasma exchange, major bleeding prevalence depends on the bleeding definition: An analysis of The Recipient Epidemiology and Donor Evaluation Study-III.在接受治疗性血浆置换的住院患者中,主要出血的发生率取决于出血的定义:对受体流行病学和供体评估研究 III 的分析。
J Clin Apher. 2023 Dec;38(6):694-702. doi: 10.1002/jca.22080. Epub 2023 Aug 7.
5
A population-based analysis on the use of therapeutic plasma exchange and intravenous immunoglobulin in heparin-induced thrombocytopenia.基于人群的分析:肝素诱导的血小板减少症中治疗性血浆置换和静脉注射免疫球蛋白的应用。
Thromb Res. 2021 May;201:6-14. doi: 10.1016/j.thromres.2021.02.017. Epub 2021 Feb 18.
6
Outcomes of therapeutic plasma exchange in severe autoimmune hemolytic anemia hospitalizations: An analysis of the National Inpatient Sample.在重度自身免疫性溶血性贫血住院患者中,治疗性血浆置换的结局:对全国住院患者样本的分析。
Transfusion. 2023 Jul;63(7):1376-1383. doi: 10.1111/trf.17445. Epub 2023 Jul 3.
7
In patients with suspected immune TTP, admission source impacts hospital length of stay and time to therapeutic plasma exchange impacts clinical outcomes.在疑似免疫性 TTP 患者中,入院来源影响住院时间,而治疗性血浆置换的时间影响临床结局。
Thromb Res. 2023 Jul;227:34-39. doi: 10.1016/j.thromres.2023.05.001. Epub 2023 May 8.
8
Trends in the use of therapeutic plasma exchange in multiple myeloma.多发性骨髓瘤中治疗性血浆置换的应用趋势。
J Clin Apher. 2020 Aug;35(4):307-315. doi: 10.1002/jca.21798. Epub 2020 Jun 9.
9
Bleeding recurrence risk among hospitalized patients undergoing therapeutic plasma exchange: a multi-center study.住院患者行治疗性血浆置换后出血复发风险:一项多中心研究。
Blood Transfus. 2024 Sep;22(5):420-428. doi: 10.2450/BloodTransfus.722. Epub 2024 Jul 19.
10
The impact of red blood cell transfusion practices on inpatient mortality in variceal and non-variceal gastrointestinal bleeding patients: a 20-year US nationwide retrospective analysis.红细胞输血实践对胃食管静脉曲张和非静脉曲张性胃肠道出血患者住院死亡率的影响:一项 20 年美国全国回顾性分析。
Aliment Pharmacol Ther. 2022 Jul;56(1):41-55. doi: 10.1111/apt.16965. Epub 2022 May 19.

引用本文的文献

1
Hemostasis testing practices vary in patients with high bleeding risk undergoing therapeutic plasma exchange.对于接受治疗性血浆置换且出血风险高的患者,止血测试方法各不相同。
Blood Transfus. 2025 Jul-Aug;23(4):318-321. doi: 10.2450/BloodTransfus.983. Epub 2025 May 9.
2
Developing A Model to Predict Major Bleeding Among Hospitalized Patients Undergoing Therapeutic Plasma Exchange.建立一个预测接受治疗性血浆置换的住院患者大出血的模型。
J Clin Apher. 2025 Apr;40(2):e70013. doi: 10.1002/jca.70013.
3
Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis.
在普瑞凯希单抗时代血栓性血小板减少性紫癜出血情况的特征:一项全国性回顾性分析
Res Pract Thromb Haemost. 2024 Dec 12;9(1):102654. doi: 10.1016/j.rpth.2024.102654. eCollection 2025 Jan.
4
Bleeding recurrence risk among hospitalized patients undergoing therapeutic plasma exchange: a multi-center study.住院患者行治疗性血浆置换后出血复发风险:一项多中心研究。
Blood Transfus. 2024 Sep;22(5):420-428. doi: 10.2450/BloodTransfus.722. Epub 2024 Jul 19.
5
In hospitalized patients undergoing therapeutic plasma exchange, major bleeding prevalence depends on the bleeding definition: An analysis of The Recipient Epidemiology and Donor Evaluation Study-III.在接受治疗性血浆置换的住院患者中,主要出血的发生率取决于出血的定义:对受体流行病学和供体评估研究 III 的分析。
J Clin Apher. 2023 Dec;38(6):694-702. doi: 10.1002/jca.22080. Epub 2023 Aug 7.
6
Research priorities for therapeutic plasma exchange in critically ill patients.重症患者治疗性血浆置换的研究重点
Intensive Care Med Exp. 2023 May 8;11(1):26. doi: 10.1186/s40635-023-00510-w.